SUNNYVALE, Calif., May 5 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.
Bank of America Merrill Lynch Health Care Conference, New York, NY |
|
Tuesday, May 11, 2010 at 4.20 p.m. Eastern Time |
|
Jefferies Global Life Sciences Conference, New York, NY |
|
Tuesday, June 8, 2010 at 10.30 a.m. Eastern Time |
|
Needham Healthcare Conference, New York, NY |
|
Thursday, June 10, 2010 at 9.20 a.m. Eastern Time |
|
ThinkEquity Partner's Healthcare Conference, New York, NY |
|
Wednesday, June 16, 2010 at 10.30 a.m. Eastern Time |
|
William Blair Growth Conference, Chicago, IL |
|
Thursday, June 17, 2010 at 9.20 a.m. Central Time |
|
To access any of the live webcasts for these events, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of each webcast will be available shortly following the presentation and will remain available for at least 90 days.
About Cepheid
Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the Company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market.
CONTACTS: |
||
For Media Inquiries: |
For Investor Inquiries: |
|
Jared Tipton |
Jacquie Ross |
|
Cepheid Corporate Communications |
Cepheid Investor Relations |
|
Tel: (408) 400-8377 |
Tel: (408) 400-8329 |
|
SOURCE Cepheid
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article